The abstract is read at the publisher; the summary is JClub's.
A reproducible pre-relapse immune signature in monocytes and B cells emerges up to 3 months before relapse in relapsing-remitting MS, linked to EBV lytic reactivation programs.
- Why it matters: The cellular and molecular events that precede MS relapse are not fully defined, limiting understanding of what peripheral immune changes might forecast or shape relapse timing.
- What they did: In an observational longitudinal cohort with single-cell RNA sequencing, bulk transcriptomics, multiparameter flow cytometry, and targeted viral RT-qPCR, investigators built a time-resolved atlas around relapse and tested EBV activity in blood.
- The result: Pre-relapse B cells showed elevated EBV LMP-1 transcripts and expanded CD11c+ atypical B cells with EBV gp350, while transcriptional modules overlapped MS GWAS risk loci and EBNA-2-bound enhancers.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.